PROGRESS
London's super sewer cut modeled storm-overflow volume 86%.
London's new tunnel intercepted most of the storm-overflow volume its designers modeled for 2025.
SOURCETideway
—
ALL THE SLOP
Every serving. No expiration date. Page 2 of 6.
PROGRESS
Nearly 12,000 Californians used a new EV rebate in ten weeks.
The instant discount is reaching first-time electric-car buyers at the dealership.
SOURCECalifornia Energy Commission
—
SCIENCE
A major Alzheimer's prevention trial has randomized its first participant.
The study will test whether clearing amyloid, then adding a second mechanism, can delay inherited Alzheimer's.
SOURCEBanner Health
—
ANIMALS
Fifteen frogs the size of a pencil tip just made history.
The first Afia Birago's puddle frogs ever born under human care are now hopping at London Zoo.
SOURCELondon Zoo (ZSL)
—
SCIENCE
A tiny sensor gave people with type 2 diabetes five more hours in range.
A randomized trial found continuous glucose monitoring added about five hours a day in the target range—even without insulin.
SOURCENew England Journal of Medicine
—
SCIENCE
Ghana cut malaria deaths 98%.
Reported malaria deaths fell from 3,259 in 2011 to 52 in 2025.
SOURCEGhana Health Service
—
SCIENCE
EU regulators backed a new pancreatic-cancer pill.
An EMA committee recommended a once-daily oral RAS inhibitor for eligible adults with metastatic pancreatic cancer.
SOURCEEuropean Medicines Agency
—
SCIENCE
A Swedish CAR-T trial saw complete responses in 8 of 12 patients.
Eight complete responses. Twelve patients.
SOURCEElicera Therapeutics
—
SCIENCE
Vaccines prevented 2.2 million future deaths in one year.
The future changed 2.2 million times.
SOURCEGavi, the Vaccine Alliance
—
PROGRESS
California will offer electrification cash instead of some gas-line replacements.
A pipe budget can become a heat pump.
SOURCECalifornia Legislature / AB 2313
—
PROGRESS
Hungary is reusing fish-farm water on drought-hit land.
Post-harvest pond water is getting a second job on farms and wetlands.
SOURCEReuters
—
SCIENCE
Patient feedback cut an epilepsy monitor’s false alarms by about 80%.
A monitor improved when patients could explain what its sensors got wrong.
SOURCENational Institutes of Health / Nature Medicine
—
SCIENCE
An experimental drug shielded celiac patients during a gluten challenge.
A 32-person study found less injury and fewer symptoms—but it is still early.
SOURCEReuters / AnaptysBio
—
PROGRESS
Teenagers are unplastifying 400+ schools.
A school challenge has engaged 3,500+ young people in 23 countries to redesign everyday plastic use.
SOURCEUnplastify / Reasons to Be Cheerful
—
SCIENCE
A rare-disease drug reported zero new bone lesions through 84 weeks.
In the OPTIMA extension, adults who stayed on Pasatru had no new lesions detected between weeks 56 and 84; the placebo group had nine.
SOURCERegeneron / The Lancet
—
PROGRESS
Old buildings made room for 21,934 homes.
Nine hundred thirty-nine completed rehabilitations turned underused historic buildings back into homes, businesses, workplaces and community spaces while supporting an estimated 163,000 jobs.
SOURCENational Park Service
—
SCIENCE
River blindness transmission is gone from 11 of 13 Americas foci.
A new WHO review says transmission now remains only in the remote cross-border Yanomami Focus Area shared by Brazil and Venezuela.
SOURCEWorld Health Organization
—
ANIMALS
Georgia counted a record 4,292 loggerhead nests.
The 2026 count was the highest in Georgia’s statewide record. The long-run nesting trend has risen about 4% a year since the early 1990s.
SOURCEThe Current / Georgia DNR
—
PROGRESS
Australian homes installed 276,011 batteries in six months.
Battery installations jumped 52% from the previous half-year while households added a record 1,894 MW of rooftop solar.
SOURCERenewEconomy / Clean Energy Council
—
SCIENCE
Taiwan reached a 92.7% Hepatitis C treatment rate.
More than 7.86 million people have been screened. Diagnosis reached 92.4%, treatment 92.7%, and treatment in key high-risk groups 95%.
SOURCECommercial Times (Taiwan)
—
SCIENCE
An mRNA vaccine formulation kept working after two months at body-heat temperatures.
A preclinical formulation held onto its biological activity for more than two months at 37°C—and matched fresh material in mouse immune-response tests.
SOURCENature Biotechnology
—
ANIMALS
Eight orangutans were moved from fire-threatened forest to a protected home.
Three mother-and-young pairs and two adolescent males passed health checks before being released into a protected 23,000-hectare forest.
SOURCEANTARA News / YIARI
—
SCIENCE
A phase 3 lung-fibrosis drug preserved breathing better than placebo.
The lower dose met the trial’s main goal over 52 weeks. The higher dose did not, and the detailed results are not yet published.
SOURCEReuters / Bristol Myers Squibb
—
PROGRESS
Texas’ grid had a boring summer.
Demand broke records. The emergency alerts did not arrive. Since 2023, Texas added 19.5 GW of solar and 16 GW of battery storage.
SOURCEU.S. Energy Information Administration / ERCOT
—